ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H)

The purpose of this program is to coordinate the acceleration of biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone by � (A) facilitating collaboration between Advance Research Projects Agency for Health and other Federal agencies, relevant industries, academia, and other persons, with respect to advance high-potential, high impact biomedical and health research that cannot be readily accomplished through traditional research and commercial activity; (B) identifying and promoting revolutionary advanced in health sciences; (C) promoting high reward innovation to develop high need cures (D) ensuring that the United States maintains, global leadership and science and innovation and the highest quality of life and health for its citizens.

All types of entities are eligible, including highly qualified foreign nationals outside of the United States either alone or in collaboration with American participants when such transactions may benefit the American people. Applicants should review the Innovative Solutions Openings issued under this ARPA-H program. Nondomestic recipients are encouraged to collaborate with a domestic entity. Awards shall not be made to nondomestic entities organized under the laws of a covered foreign country.

Selection criteria will vary and are therefore provided in each Innovative Solutions Opening.

Fiscal year 2024: THEA: Transplantation of Human Eye Allografts. APECX: Antigens Predicted for Broad Viral Efficacy through Computational Experimentation. SARRTS: Supervised Autonomous Robotics Renal Tumor Surgery. MASCOT: Manufacturing Agile and SCalable Organoid Tumor models. PSI: Precision Surgical Interventions Fiscal year 2025: DACART: CAR T-Cellular Vaccine for Solid Cancers. AFC-HEALTH: The American Family Cohort-Enhancing and Validating Primary Care Data for Improving Urban and Rural Health. CHD: Eliminating Out-of-Hospital Adverse Events for Everyone with Congenital Heart Disease. CHI: Cyber Health Intelligence.